OtiTopic

Philip Morris International Acquires Inhaled Drug Specialist OtiTopic; Growing Pipeline of “Beyond Nicotine” Inhaled Therapeutic Products

PMI’s expertise and Beyond Nicotine portfolio companies to speed ASPRIHALE® to market LAUSANNE, Switzerland–(BUSINESS WIRE)–Philip Morris International Inc. (PMI) (NYSE:…

Read More »